Richard C Bump

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi Long-term efficacy of duloxetine in women with stress urinary incontinence
    Richard C Bump
    Lilly Research Laboratories, Indianapolis, IN 46285, USA
    BJU Int 102:214-8. 2008
  2. doi Reductions in stress urinary incontinence episodes: what is clinically important for women?
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Neurourol Urodyn 29:344-7. 2010
  3. doi The POP-Q system: two decades of progress and debate
    Richard C Bump
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, 46285, IN, USA
    Int Urogynecol J 25:441-3. 2014
  4. ncbi Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response
    Richard C Bump
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Obstet Gynecol 102:76-83. 2003
  5. ncbi Validation of two global impression questionnaires for incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Am J Obstet Gynecol 189:98-101. 2003
  6. doi Use of preoperative prolapse reduction stress testing and the risk of a second surgery for urinary symptoms following laparoscopic sacral colpoperineopexy
    Jean Park
    Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Indiana University Health Methodist Hospital, Indiana University School of Medicine, Indianapolis, IN, USA
    Int Urogynecol J 23:857-64. 2012
  7. ncbi Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Urology 67:1304-8. 2006
  8. ncbi The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, IN, USA
    Am J Obstet Gynecol 191:194-7. 2004
  9. ncbi Pharmacological agents used for the treatment of stress urinary incontinence in women
    Lars Viktrup
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Curr Med Res Opin 19:485-90. 2003
  10. ncbi Validation of a clinical algorithm to diagnose stress urinary incontinence for large studies
    Ilker Yalcin
    Lilly Research Laboratories and Methodist Hospital, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Urol 171:2321-5. 2004

Detail Information

Publications26

  1. doi Long-term efficacy of duloxetine in women with stress urinary incontinence
    Richard C Bump
    Lilly Research Laboratories, Indianapolis, IN 46285, USA
    BJU Int 102:214-8. 2008
    ....
  2. doi Reductions in stress urinary incontinence episodes: what is clinically important for women?
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Neurourol Urodyn 29:344-7. 2010
    ..To expand our understanding of the clinical importance to patients with stress urinary incontinence (SUI) of reductions in incontinence episode frequency (IEF) that fall short of a complete cure...
  3. doi The POP-Q system: two decades of progress and debate
    Richard C Bump
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, 46285, IN, USA
    Int Urogynecol J 25:441-3. 2014
    ..The invitation led me to dig into old files and recall-through a series of insightful emails, faxes, meeting summaries and draft documents-a document made possible by the combined efforts of an extraordinary group of individuals. ..
  4. ncbi Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response
    Richard C Bump
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Obstet Gynecol 102:76-83. 2003
    ..To investigate the relationship between the symptom of mixed urinary incontinence and incontinence severity, urodynamic findings, and treatment response...
  5. ncbi Validation of two global impression questionnaires for incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Am J Obstet Gynecol 189:98-101. 2003
    ..The purpose of this study was to assess the construct validity of two global assessment questions, the Patient Global Impression of Severity and of Improvement, in female patients with stress urinary incontinence...
  6. doi Use of preoperative prolapse reduction stress testing and the risk of a second surgery for urinary symptoms following laparoscopic sacral colpoperineopexy
    Jean Park
    Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Indiana University Health Methodist Hospital, Indiana University School of Medicine, Indianapolis, IN, USA
    Int Urogynecol J 23:857-64. 2012
    ....
  7. ncbi Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Urology 67:1304-8. 2006
    ....
  8. ncbi The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, IN, USA
    Am J Obstet Gynecol 191:194-7. 2004
    ..The aim of this study was to examine the relationship between previous treatment experience and baseline urinary incontinence severity with placebo response...
  9. ncbi Pharmacological agents used for the treatment of stress urinary incontinence in women
    Lars Viktrup
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Curr Med Res Opin 19:485-90. 2003
    ..A new centrally-acting compound with dual activity as a balanced serotonin and norepinephrine reuptake inhibitor, duloxetine, may offer a promising new approach for treatment...
  10. ncbi Validation of a clinical algorithm to diagnose stress urinary incontinence for large studies
    Ilker Yalcin
    Lilly Research Laboratories and Methodist Hospital, Indiana University School of Medicine, Indianapolis, Indiana, USA
    J Urol 171:2321-5. 2004
    ..Such an algorithm would have applicability to ensure that the majority of women entering large SUI clinical trials would have urodynamic SUI and/or the condition of SUI without performing urodynamic testing in all subjects...
  11. doi De novo stress urinary incontinence after negative prolapse reduction stress testing for total vaginal mesh procedures: incidence and risk factors
    Seshadri Kasturi
    Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA
    Am J Obstet Gynecol 205:487.e1-4. 2011
    ..Secondary objective was to identify associated risk factors...
  12. ncbi Healthcare utilization among women who undergo surgery for stress urinary incontinence
    Kraig S Kinchen
    Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN 46278, USA
    Int Urogynecol J Pelvic Floor Dysfunct 15:154-9. 2004
    ..We examined medical care and pharmaceutical use for women undergoing continence surgery. This information may be important to patients and physicians discussing treatment options...
  13. ncbi Duloxetine compared with placebo for treating women with symptoms of overactive bladder
    William D Steers
    University of Virginia, Charlottesville, Virginia, USA
    BJU Int 100:337-45. 2007
    ..To evaluate duloxetine (a serotonin-noradrenaline reuptake inhibitor) in women with symptoms of overactive bladder (OAB), as it has been shown to increase the bladder capacity in an animal model...
  14. ncbi Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence
    Alfred E Bent
    Greater Baltimore Medical Center, Baltimore, Maryland, USA
    Neurourol Urodyn 27:212-21. 2008
    ..Evaluate duloxetine in the treatment of women with mixed urinary incontinence (MUI)...
  15. ncbi Prevalence and outcomes of continence surgery in community dwelling women
    Ananias C Diokno
    Department of Urology, William Beaumont Hospital, Royal Oak, Michigan, USA
    J Urol 170:507-11. 2003
    ..We determined the prevalence of continence surgery as well as patient reported outcomes in community dwelling women...
  16. ncbi Burden of stress urinary incontinence for community-dwelling women
    Nancy H Fultz
    Institute for Social Research, University of Michigan, 426 Thompson Street, PO Box 1248, Ann Arbor, MI 48106 1248, USA
    Am J Obstet Gynecol 189:1275-82. 2003
    ..The purpose of this study was to better understand the subjective bothersomeness of stress urinary incontinence symptoms and their impact on the quality of life of community-dwelling women...
  17. ncbi Duloxetine versus placebo in the treatment of stress urinary incontinence
    Peggy A Norton
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, USA
    Am J Obstet Gynecol 187:40-8. 2002
    ..The purpose of this study was to assess the efficacy and safety of duloxetine, a selective inhibitor of serotonin and norepinephrine reuptake, in the treatment of stress urinary incontinence...
  18. ncbi Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence
    David Castro-Diaz
    Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
    Int Urogynecol J Pelvic Floor Dysfunct 18:919-29. 2007
    ..Starting duloxetine at 20 mg BID for 2 weeks before increasing to 40 mg BID significantly improved tolerability but did not impact duloxetine efficacy after all the subjects had been on 40 mg BID for at least 2 weeks...
  19. ncbi Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence
    Roger R Dmochowski
    Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee, USA
    J Urol 170:1259-63. 2003
    ..In this first phase 3 study we assessed the efficacy and safety of duloxetine in women with stress urinary incontinence (SUI)...
  20. ncbi A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence
    Gamal M Ghoniem
    Cleveland Clinic Florida, Weston, Florida, USA
    J Urol 173:1647-53. 2005
    ..In addition, we compared the effectiveness of combined treatment with single treatments, single treatments with each other and single treatments with no treatment...
  21. ncbi Pharmacological treatment of women awaiting surgery for stress urinary incontinence
    Linda Cardozo
    Kings College Hospital, London, United Kingdom
    Obstet Gynecol 104:511-9. 2004
    ..The aim of this trial was to assess its efficacy for women with severe stress urinary incontinence...
  22. ncbi Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence
    Philip van Kerrebroeck
    Department of Urology, University Hospital Maastrecht, Netherlands
    BJOG 111:249-57. 2004
    ..To assess the efficacy and safety of duloxetine in women with stress urinary incontinence...
  23. ncbi Medication use and control of urination among community-dwelling older adults
    Christine M Ruby
    Duke University Medical Center, Veterans Affairs Medical Center, University of North Carolina, USA
    J Aging Health 17:661-74. 2005
    ..The purpose of this study is to evaluate whether the use of medications with urological activity (UA) is associated with self-reported difficulty in control of urination...
  24. ncbi Advising prospective mothers about the maternal morbidity of vaginal childbirth
    Richard C Bump
    Am J Obstet Gynecol 187:823. 2002
  25. ncbi Medical and self-care practices reported by women with urinary incontinence
    Ananias C Diokno
    Department of Urology, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 438, Royal Oak, Mich 48073, USA
    Am J Manag Care 10:69-78. 2004
    ..To determine the extent to which women with incontinence have been identified by physicians, the coping and treatment strategies that incontinent women use, and the factors associated with treatment strategy utilization...
  26. ncbi Sexual function in women with urinary incontinence and pelvic organ prolapse
    Matthew D Barber
    Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Obstet Gynecol 99:281-9. 2002
    ..To compare sexual function in women with urinary incontinence and pelvic organ prolapse and to determine the effects of therapy on sexual function...